Assess products based on strategic fit, market potential and financial viability.

external asset evaluation support.

Make more informed decisions from factual data, enriched with the sentiment and opinion of patients, clinicians, payers & investors.

The challenge: Evaluating assets and companies requires significant internal capability and external consulting can slow you down when you need to make decisions quickly.

The solution: Our technology driven approach draws upon our full range of tools to provide you with the evidence you need to make your decision and reach a valuation, faster than your competition.


  • Clinical and competitive landscape assessments
  • Epidemiology across your target markets
  • Physician, patient and investor perspectives on disease, technology, product and company  
  • We can address specific questions such as safety concerns and competing technologies
  • Prioritisation of indications  
  • Pricing assumptions for orphan or new assets in an established market

Enhancing strategic decision-making: An acquisition case study.
View this case study

All delivered as strategic reports, interactive intelligence dashboards and scenario planning tools, placing an optimal strategy at your fingertips.